Effective treatment of osmotic demyelination syndrome with corticosteroid therapy: A case report

  • Pham Cuong 108 Military Central Hospital
  • Nguyen Van Tuyen 108 Military Central Hospital
  • Dinh Thi Hai Ha 108 Military Central Hospital
  • Thach Thi Ngoc Khanh 108 Military Central Hospital

Main Article Content

Tóm tắt

Background: Osmotic demyelination syndrome (ODS) is characterized by widespread degeneration of myelin within the central nervous system (CNS) and has no established treatment. A limited number of cases have reported positive outcomes with corticosteroid in the treatment of ODS. We report the case of complete recovery of ODS with corticosteroid. Case presentation: A 48-year-old man presented with a stupor condition and exhausted. He was hospitalized at the Endocrinology Department with hyponatraemia, which was rapidly corrected with hypertonic saline from 103 to 116mmol/L. He was transferred to the Stroke Department because of worsening consciousness, arising rigidity and bradykinesia of the extremyties, worsening dysarthria and bradyphrenia. A brain magnetic resonance imaging (MRI) scan revealed later on pontine myelinolysis. He was commenced on corticoid 11 days after rapid correction of sodium. His status began to improve gradually after 10 days from starting of corticosteroid therapy and at 44 day-follow-up had no neurological deficit. Conclusion: Corticosteroid therapy can be considered as an effective treatment modality in osmotic demyelination syndrome.

Article Details

Các tài liệu tham khảo

1. Lambeck J, Hieber M, Dreßing A, Niesen WD (2019) Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int 116(35-36): 600-606.
2. Ahmed A, Asimi R, Sharma A, Nazir S (2007) Diagnosis: Osmotic myelinolysis (central pontine myelinolysis and extrapontine myelinolysis). Ann Saudi Med 27(4): 308-311.
3. Lien YH, Shapiro JI, Chan L (1991) Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 88(1): 303-309.
4. Gankam-Kengne F, Couturier BS, Soupart A, Brion JP, Decaux G (2017) Osmotic stress-induced defective glial proteostasis contributes to brain demyelination after hyponatremia treatment. J Am Soc Nephrol 28(6): 1802-1813.
5. Adams RD, Victor M, Mancall EL (1959) Central pontine myelinosis: A hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol Psychiatry 81: 154-156.
6. Uchino A, Yuzuriha T, Murakami M, Endoh K, Hiejim S, Koga H et al (2003) Magnetic resonance imaging of sequelae of central pontine myelinosis in chronic alcohol abusers. Neuroradiology 45: 877-880.
7. Sakamoto E, Hagiwara D, Masahiro Yamamoto (2007) Complete recovery of central pontine myelinolysis by high dose pulse therapy with methylprednisolone. The Journal of the Japanese Society of Internal Medicine 96(10): 2291-2293.
8. Corona G, Simonetti L, Giuliani C, Sforza A, Peri A (2014) A case of osmotic demyelination syndrome occurred after the correction of severe hyponatremia in hyperemesis gravidarum. BMC Endocr Disord
14: 34.
9. Sugimura Y, Murase T, Takefuji S (2005) Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 192(1): 178-183.
10. Abdul Halim S, Mohd Amin NA (2018) Treatment response in osmotic demyelination syndrome presenting as severe parkinsonism, ptosis and gaze palsy. BMJ Case Rep 21. doi: 10.1136/bcr-2018-225751.